GCM
Glenview Capital Management Portfolio holdings
AUM
$5.49B
Turnover
46.55%
1-Year Est. Return
46.89%
This Fund
S&P 500
This Quarter
Est. Return
+5.55%
1 Year Est. Return
+46.89%
3 Year Est. Return
+94.27%
5 Year Est. Return
+129.04%
10 Year Est. Return
+529.98%
AUM
$14.7B
AUM Growth
-$2.44B
(-14%)
Cap. Flow
-$3.04B
Cap. Flow
% of AUM
-20.76%
Top 10 Holdings %
Top 10 Hldgs %
43.33%
Holding
58
New
4
Increased
14
Reduced
30
Closed
8
Avg Time Held Equity + Options
2.2
years
Top 10 Avg Time Held Equity + Options
0.8
years
Top 20 Avg Time Held Equity + Options
1.9
years
Avg Time Held Equity only
2.2
years
Top 10 Avg Time Held Equity only
0.8
years
Top 20 Avg Time Held Equity only
1.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$175M |
| 2 |
nVent Electric
NVT
|
+$166M |
| 3 |
Microsoft
MSFT
|
+$120M |
| 4 |
Charter Communications
CHTR
|
+$99.7M |
| 5 |
Fortune Brands Innovations
FBIN
|
+$92.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCA Healthcare
HCA
|
+$660M |
| 2 |
T-Mobile US
TMUS
|
+$275M |
| 3 |
Labcorp
LH
|
+$237M |
| 4 |
Elevance Health
ELV
|
+$233M |
| 5 |
Cardinal Health
CAH
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 46.25% |
| 2 | Materials | 11.06% |
| 3 | Industrials | 10.97% |
| 4 | Communication Services | 7.42% |
| 5 | Consumer Discretionary | 7.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SHPG
1
DELISTED
Shire pic
SHPG
| $838M | 5.71% |
4,961,899
-1,039,785
| -17% | -$168M |
2017 Q1
5 quarters
|
|
2
DuPont de Nemours
DD
$17.3B
| $761M | 5.19% |
4,560,400
-575,926
| -11% | -$96.4M |
2014 Q3
15 quarters
|
|
3
FMC
FMC
$1.26B
| $715M | 4.88% |
9,241,768
-2,529,091
| -21% | -$188M |
2015 Q1
13 quarters
|
|
4
McKesson
MCK
$114B
| $628M | 4.29% |
4,710,544
+312,273
| +7% | +$45.7M |
2016 Q4
6 quarters
|
|
5
Tenet Healthcare
THC
$21.9B
| $601M | 4.1% |
17,895,314
| – | – |
2013 Q2
20 quarters
|
|
6
IQVIA
IQV
$43.2B
| $595M | 4.06% |
5,961,345
-1,758,638
| -23% | -$176M |
2016 Q2
8 quarters
|
|
|
AET
7
DELISTED
Aetna Inc
AET
| $570M | 3.89% |
3,104,322
+270,105
| +10% | +$48.1M |
2013 Q4
18 quarters
|
|
|
FDC
8
DELISTED
First Data Corporation
FDC
| $559M | 3.81% |
26,695,274
+1,222,666
| +5% | +$22.7M |
2016 Q2
8 quarters
|
|
|
9
HCA Healthcare
HCA
$102B
| $547M | 3.73% |
5,332,923
-6,526,669
| -55% | -$660M |
2013 Q2
20 quarters
|
|
|
ESRX
10
DELISTED
Express Scripts Holding Company
ESRX
| $539M | 3.68% |
6,979,569
+2,337,583
| +50% | +$175M |
2018 Q1
1 quarter
|
|
11
Thermo Fisher Scientific
TMO
$250B
| $528M | 3.6% |
2,546,601
-416,142
| -14% | -$88.3M |
2013 Q2
20 quarters
|
|
12
Newell Brands
NWL
$2.33B
| $516M | 3.52% |
19,996,871
-5,972,116
| -23% | -$156M |
2017 Q4
2 quarters
|
|
13
Flex
FLEX
$36.9B
| $467M | 3.18% |
43,886,491
+552,726
| +1% | +$6.2M |
2013 Q2
20 quarters
|
|
14
eBay
EBAY
$51.7B
| $433M | 2.95% |
11,938,688
+443,931
| +4% | +$17.3M |
2016 Q4
6 quarters
|
|
15
DXC Technology
DXC
$2.01B
| $426M | 2.9% |
5,282,331
-801,348
| -13% | -$68.9M |
2017 Q2
4 quarters
|
|
16
DELISTED
Walgreens Boots Alliance
WBA
| $421M | 2.88% |
7,022,969
-1,161,958
| -14% | -$74.8M |
2017 Q2
4 quarters
|
|
17
Alphabet (Google) Class A
GOOGL
$4.25T
| $373M | 2.54% |
6,602,020
-1,432,540
| -18% | -$77.9M |
2015 Q4
10 quarters
|
|
18
CVS Health
CVS
$115B
| $349M | 2.38% |
5,422,240
-2,372,148
| -30% | -$156M |
2017 Q3
3 quarters
|
|
19
Universal Health Services
UHS
$10.9B
| $326M | 2.22% |
2,923,093
-1,147,625
| -28% | -$134M |
2016 Q3
7 quarters
|
|
|
20
Elevance Health
ELV
$92.2B
| $304M | 2.07% |
1,275,662
-1,005,673
| -44% | -$233M |
2014 Q1
17 quarters
|
|
|
AGN
21
DELISTED
Allergan plc
AGN
| $296M | 2.02% |
1,772,481
+245,591
| +16% | +$39.4M |
2017 Q4
2 quarters
|
|
22
Cigna
CI
$76.3B
| $284M | 1.94% |
1,670,007
-480,771
| -22% | -$83.2M |
2013 Q2
20 quarters
|
|
23
DELISTED
Paramount Global Class B
PARA
| $268M | 1.83% |
4,763,287
-1,809,827
| -28% | -$94.5M |
2013 Q2
20 quarters
|
|
24
FedEx
FDX
$68.3B
| $266M | 1.82% |
1,173,426
-13,791
| -1% | -$3.42M |
2017 Q3
3 quarters
|
|
25
Williams Companies
WMB
$89.7B
| $262M | 1.78% |
9,648,585
-750,937
| -7% | -$19.8M |
2016 Q2
8 quarters
|
|
Similar funds
GCM
VCM
ACM
MC
SCM
NC
EI
AP
Glenview Capital Management's Q2 2018 Portfolio in Review
As of Q2 2018, Glenview Capital Management held 58 positions worth $14.7B, down 14% from $17.1B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Glenview Capital Management withdrew a net $3.04B in Q2 2018, closing 8 positions and reducing 30 holdings. Its most notable exit was T-Mobile US, an estimated $275M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 46% of assets, down from 48% a quarter earlier, followed by Materials and Industrials.
Against the trend, Glenview Capital Management opened a new position in nVent Electric worth $160M.
- Glenview Capital Management's largest Q2 2018 buy was nVent Electric: 6,368,500 shares worth $160M.
- Glenview Capital Management added most to Express Scripts Holding Company in Q2 2018, an estimated $175M increase.
- Glenview Capital Management's biggest Q2 2018 reduction was HCA Healthcare, cutting an estimated $660M.
- Glenview Capital Management fully exited T-Mobile US in Q2 2018, selling an estimated $275M.
- Glenview Capital Management's ten largest holdings make up 43% of its $14.7B portfolio in Q2 2018.
- Glenview Capital Management opened 4 new positions and closed 8 in Q2 2018.
- Glenview Capital Management's portfolio value fell 14% quarter-over-quarter to $14.7B.
Based on Glenview Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.